Cempra, Inc. (NASDAQ:CEMP) shares moved up 17.12% in last trading session and ended the day at $23.53. CEMP has a return on assets of -47.90%. Cempra, Inc. (NASDAQ:CEMP) quarterly performance is -43.05%.
On 22 October, Cempra, Inc. (NASDAQ:CEMP) reported financial results for the quarter ended September 30, 2015 and provided an update on recent corporate developments. For the quarter ended September 30, 2015, Cempra reported a net loss of $27.6 million, or $0.63 per share, compared to a net loss of $11.4 million, or $0.34 per share, for the third quarter in 2014.
Alamos Gold, Inc. (NYSE:AGI) ended the last trading day at $4.22. Company weekly volatility is calculated as 5.98%. Alamos Gold, Inc. (NYSE:AGI) showed a weekly performance of -3.87%.
Alamos Gold, Inc. (NYSE:AGI) was downgraded by analysts at Canaccord Genuity from a “buy” rating to a “hold” rating in a research report issued on Monday, The Fly reports.
On 28 October, The Procter & Gamble Company (NYSE:PG) shares decreased -1.01% and was closed at $76.51. PG EPS growth in last 5 year was -2.50%. The Procter & Gamble Company (NYSE:PG) year to date (YTD) performance is -13.26%.
The Procter & Gamble Company (NYSE:PG) sold its first euro-denominated bond in two years Tuesday, the latest in a wave of U.S. giants to seek cheap funding in Europe. According to a notice released Tuesday by banks working on the deal, P&G, the world’s largest consumer-goods company, sold an eight-year euro-denominated €1.25 billion bond at an interest rate of 1.125%. The proceeds will be used for general corporate purposes, the notice said.
Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) shares increased 5.72% in last trading session and ended the day at $4.99. NWBO has a return on assets of -354.70%. Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) quarterly performance is -56.00%.
On 21 October, Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) announced that the Company has entered into agreement for funding of $30 million from Woodford Investment Management in the UK (“Woodford”).Woodford will purchase $30 million of the Company’s common stock at $5.50 per share, for a total of 5,454,545 shares, raising Woodford’s total holdings to 25,915,937 shares, or about 28.1% of the Company.
Discovery Laboratories Inc. (NASDAQ:DSCO) caters to the Healthcare space. Its weekly performance is -7.27%. On the last day of trading company shares ended up at $0.31. Discovery Laboratories Inc. (NASDAQ:DSCO) distance from 50-day simple moving average (SMA50) is -0.28%.
On 21 October, Discovery Laboratories Inc. (NASDAQ:DSCO) announced that it has completed enrollment in the AEROSURF phase 2a dose expansion clinical trial to assess the administration of higher doses of AEROSURF in premature infants 29 to 34 week gestational age (GA) with respiratory distress syndrome (RDS).
Leave a Reply